Page last updated: 2024-10-28

hydralazine and Tachycardia, Ventricular

hydralazine has been researched along with Tachycardia, Ventricular in 4 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).

Research Excerpts

ExcerptRelevanceReference
"Male patients aged 18-75 years with chronic heart failure were randomized to enalapril or hydralazine-isosorbide dinitrate."9.07Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. The V-HeFT II VA Cooperative Studies Group. ( Carson, P; Cintron, GB; Cohn, JN; Fletcher, RD; Johnson, G; Orndorff, J, 1993)
"Male patients aged 18-75 years with chronic heart failure were randomized to enalapril or hydralazine-isosorbide dinitrate."5.07Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. The V-HeFT II VA Cooperative Studies Group. ( Carson, P; Cintron, GB; Cohn, JN; Fletcher, RD; Johnson, G; Orndorff, J, 1993)
"Treatment with captopril significantly reduced the incidence of VT/Vf although hydralazine failed to reduce the incidence."1.29[Effect of chronic antihypertensive treatment on ischemia-induced lethal ventricular tachyarrhythmias and electrophysiological property in hypertrophied rat hearts]. ( Yokoshiki, H, 1993)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yokoshiki, H1
Fletcher, RD1
Cintron, GB1
Johnson, G1
Orndorff, J1
Carson, P1
Cohn, JN1
Ooie, T1
Takahashi, N1
Saikawa, T1
Iwao, T1
Hara, M1
Sakata, T1
Li, D1
Shinagawa, K1
Pang, L1
Leung, TK1
Cardin, S1
Wang, Z1
Nattel, S1

Trials

1 trial available for hydralazine and Tachycardia, Ventricular

ArticleYear
Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. The V-HeFT II VA Cooperative Studies Group.
    Circulation, 1993, Volume: 87, Issue:6 Suppl

    Topics: Death, Sudden, Cardiac; Drug Therapy, Combination; Electrocardiography, Ambulatory; Enalapril; Heart

1993

Other Studies

3 other studies available for hydralazine and Tachycardia, Ventricular

ArticleYear
[Effect of chronic antihypertensive treatment on ischemia-induced lethal ventricular tachyarrhythmias and electrophysiological property in hypertrophied rat hearts].
    [Hokkaido igaku zasshi] The Hokkaido journal of medical science, 1993, Volume: 68, Issue:6

    Topics: Action Potentials; Animals; Captopril; Drug Administration Schedule; Electrophysiology; Hemodynamics

1993
Suppression of cesium-induced ventricular tachyarrhythmias by atrial natriuretic peptide in rabbits.
    Journal of cardiac failure, 2000, Volume: 6, Issue:3

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Natriuretic Fact

2000
Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure.
    Circulation, 2001, Nov-20, Volume: 104, Issue:21

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Fibrillation; Dogs; Electr

2001